Whitney Award Winner Milap Nahata Honored at ASHP Summer Meetings

Kate Traynor
Kate Traynor Senior Writer, ASHP News Center Published: June 14, 2023
Whitney Award Winner Milap C. Nahata

Milap C. NahataMilap C. Nahata, PharmD, MS, FASHP, FCCP, FAPhA, FPPA, delivered the 2023 Harvey A.K. Whitney Lecture on Tuesday, June 13, at a special reception at the 2023 ASHP Summer Meetings in Baltimore, Maryland.

The Harvey A.K. Whitney Lecture Award is given annually to a person of high moral character, good citizenship, and elevated professional ideals who has made significant contributions to health-system pharmacy.

Nahata is professor emeritus of pharmacy, pediatrics, and internal medicine at The Ohio State University colleges of pharmacy and medicine. His clinical practice and patient-focused research have fundamentally shaped the field of pediatric pharmacy, encompassing all aspects of providing comprehensive medication management for children.


Nahata has published over 600 peer-reviewed articles and book chapters. Notably, his studies with azithromycin were pivotal in its approval by the Food and Drug Administration for use in children. He is an author and co-editor of five books, including Pediatric Drug Formulations, one of the most widely used resources in health-system practice, and Pediatric Pharmacotherapy and Pediatric Pharmacotherapy Self-Assessment. He also contributed to the Institute of Medicine reports Emergency Care for Children: Growing Pains and Safe and Effective Medicines for Children. He is the editor in chief of the Annals of Pharmacotherapy.

He received a Bachelor of Science in pharmacy from the University of Bombay, a Master of Science in pharmaceutics, and a Doctor of Pharmacy from Duquesne University School of Pharmacy. He completed a residency at Buffalo General Hospital.

Posted June 14, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information